<DOC>
	<DOCNO>NCT01430663</DOCNO>
	<brief_summary>Diagnosing invasive pulmonary aspergillosis ( IPA ) remain challenge patient ( pt ) hematological malignancy . The clinical significance test bronchoalveolar lavage ( BAL ) sample polymerase chain reaction ( PCR ) Aspergillus galactomannan ( GM ) ELISA unclear , BAL cutoff GM clearly define yet . Using validated nested PCR assay GM ELISA , prospectively examine BAL sample hematological patient high risk PA .</brief_summary>
	<brief_title>Diagnosing Pulmonary Aspergillosis Patients With Hematological Malignancies : A Multicentre Prospective Evaluation Aspergillus PCR Assay Galactomannan ELISA Bronchoalveolar Lavage Samples</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<criteria>hematological patient lung infiltrates high risk invasive aspergillosis patient without informed consent</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>aspergillosis</keyword>
	<keyword>bronchoalveolar lavage</keyword>
	<keyword>galactomannan</keyword>
	<keyword>pcr</keyword>
	<keyword>hematological patient</keyword>
</DOC>